The Personalized Psychological Treatment for Psychosis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorPolish Academy of Sciences

About this trial

The main aim of the clinical trial is to validate the Machin Learning (ML) predictive model for personalized Metacognitive Training (MCT) by comparing classic MCT to personalized MCT (P-MCT) among patients diagnosed with psychosis who had a history of delusions. More precisely, we will compare classic MCT to P-MCT in a randomized clinical trial.We expect personalised MCT treatment will see more improvement than classical MCT in outcome variables measuring treatment efficacy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Inpatients and outpatients with a DSM-IV-R and DSM-5 diagnosis of non-affective psychosis or Clinical High Risk for psychosis.

Presence of positive symptoms during the last year (PANSS delusions, suspiciousness or grandiosity >=3).

Adults, 18 - 65 years of age

Stable condition with no expected changes in medication (information from clinical services).

Disqualifiers

Having received MCT in the previous year.

Neurological disorder, a history of head trauma or premorbid IQ below 70 (based on medical reports and/or other sources);

A score above 5 in the "Hostility" and the "Suspiciousness" items of the PANSS Positive subscale (to preserve group dynamics).

aggressive behavior (reports from clinical services if available)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Psychological treatment (P-MCT)

    Behavioral

    Personalization will be performed according to the results obtained from the platform. Both the classic MCT and personalized MCT will be the same with regard to specific modules that are offered to patients. However, the personalized MCT will have personalized homeworks that target specific factors, in which patients have deficits. For instance, patients with deficits in self-esteem (based on the results from the platform) will be provided with homework addressing this aspect. We identified five domains that will be personalized: 1. self-esteem; 2. cognitive insight; 3. delusions; 4. positive symptoms; 5. completion.

  • Psychological treatment (MCT)

    Behavioral

    Metacognitive training is a cognitive approach to the treatment of positive symptoms in psychosis. Metacognitive training consists of ten modules referring to common cognitive issues and biases in solving problems in schizophrenia. The topics of MCT include the following: attribution blaming and taking credit (module 1), jumping to conclusions (modules 2 \& 7), changing beliefs (module 3), deficits in theory of mind and social cognition (modules 4 and 6), overconfidence in (memory) errors (module 5), mood (module 8), self-esteem (9) and stigma (10). Each session lasts 45-60 min and follows a protocol defined in the 'Metacognitive Training for Psychosis (MCT)' manual. The MCT for Schizophrenia programme will be applied to the group (6-12 persons) applied by therapists in each center. The training format (online or in-person) as well as the frequency (1 or 2 times per week) will vary depending on the center.

Treatment groups

252 Participants
are divided into 2 treatment groups
Group A: Personalized MCT (P-MCT)Experimental treatment 1 intervention
Group B: Metacognitive training (MCT)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Sociodemographic Questionnaire

A sociodemographic sheet will be captured the following information: age, gender/sex, marital status, years of education, living situation, number of siblings, whether they live in rural or urban areas, employment status, symptom onset, previous hospitalisations, history of suicide attempts, family mental health history, current substance use, current pharmacological treatment (name and dosage), diagnosis (options: schizophrenia,unspecified psychotic disorder, schzoaffective disorder, delusional disorder, brief psychotic disorder, schizophreniform disorder), comorbidity, other medical illnesses, and in female patients, age at menarche, age at menopause, hormone treatment (if applicable), menstrual cycle description, date of last menstrual period, amenorrhoea.

Time frame
Baseline
2

PSYRATS

Psychotic Symptom Rating Scale. The PSYRATS comprises hallucinations (11 items) and delusions (6 items) subscales, each one designed to assess the psychological aspects of the symptoms on a five-point scale, from 0 to 4.

Time frame
baseline, post-treatment and 6-month follow-up
3

PANSS

The Positive and Negative Syndromes Scale.PANSS is a semi-structured interview assessing 30 symptoms on a 7-point scale, from 1 (absent) to 7 (extreme). Symptoms are rated over seven days prior to the assessment.

Time frame
baseline, post-treatment and 6-month follow-up
4

RSES

Rosenberg's Self-Esteem Scale.A 10-item scale that measures global self-worth by measuring both positive and negative feelings about the self. The scale is believed to be unidimensional. All items are answered using a 4-point Likert scale ranging from strongly agree to strongly disagree.

Time frame
baseline, post-treatment and 6-month follow-up

Secondary outcomes

1

GAF

Global Assessment of Functioning. A numeric scale used by mental health clinicians and physicians to rate subjectively the social, occupational, and psychological functioning of an individual, i.e., how well one is meeting various problems in living. Scores range from 100 (extremely high functioning) to 1 (severely impaired).

Time frame
baseline, post-treatment and 6-month follow-up
2

DIAMOND

structured clinical interview that queries the DSM-5 diagnostic criteria

Time frame
baseline
3

WHOQOL-BREF

The WHOQOL-BREF is a 26-item instrument consisting of four domains: physical health (7 items), psychological health (6 items), social relationships (3 items), and environmental health (8 items); it also contains QOL and general health items. Each item of the WHOQOL-BREF is scored from 1 to 5 on a response scale, which is stipulated as a five-point ordinal scale.

Time frame
baseline, post-treatment and 6-month follow-up
4

TEC

Traumatic Experience Checklist. The TEC is a self-report measure addressing 29 types of potentially traumatic events. It is a 29-item retrospective self-report scale. It is a reliable and valid self-report instrument that can be used in clinical practice and research. Different scores can be calculated, including a cumulative score, and scores for emotional neglect, emotional abuse, physical abuse, sexual harassment, sexual abuse, and bodily threat from a person. Only 19-item will be used.

Time frame
baseline

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Polish Academy of Sciences

Lead sponsor

Fundació Sant Joan de Déu

Collaborator

Universitätsklinikum Hamburg-Eppendorf

Collaborator

University Hospitals of Strasbourg

Collaborator

Universitat Politècnica de Catalunya

Collaborator

Universidad de Valparaiso

Collaborator

This trial is not recruiting at the moment. You can still explore other options: